New York’s legislative bodies have taken a significant step toward enhancing food safety transparency by passing a bill that mandates companies to disclose ingredients they have self-affirmed as Generally Recognized as Safe (GRAS). This move aligns with a broader federal initiative championed by figures like Robert F. Kennedy Jr., aiming to reform a regulatory pathway that critics argue has allowed potentially harmful substances into the food supply with insufficient oversight. The legislation, if signed into law, would position New York as a leader in requiring such disclosures, prompting a potential ripple effect across the nation’s food industry.
The GRAS classification, established by Congress in 1958 and modified in 1972, allows food manufacturers to introduce new ingredients without undergoing the formal review process of the U.S. Food and Drug Administration (FDA). Instead, companies can self-determine an ingredient’s safety based on scientific assessments, often conducted by internal or external expert panels. While intended to streamline the introduction of safe ingredients and protect proprietary information, this self-affirmation provision has become a focal point of concern for consumer advocacy groups and some policymakers who view it as a significant loophole in food safety regulation.
The proposed New York bill, officially known as the Food Safety Chemical and Disclosure Act, would require companies to report to state regulators any ingredients they have self-determined as GRAS, but have not disclosed to the federal FDA. This proactive legislative action by New York anticipates potential federal changes, which, while proposed, could face protracted review processes and industry opposition. Senator Brian Kavanagh, a co-sponsor of the bill, emphasized the critical nature of this reform, stating, "Today, in spite of an onslaught of misinformation from the food industry, we are taking a critical step toward protecting New Yorkers from having to guess what potentially harmful chemicals might be lurking in the food we eat."
This legislation makes New York the first state to explicitly mandate that large companies restrict the sale of ingredients that have been self-determined as GRAS without federal disclosure. The FDA, under the influence of initiatives such as those advocated by Health Secretary Robert F. Kennedy Jr., has indeed proposed a national rule to reform the self-affirmed GRAS pathway. However, the timeline for federal implementation remains uncertain, with industry groups already signaling potential legal challenges. Jessica Hernandez, legislative director of the Environmental Working Group, lauded New York’s initiative, noting, "New York is stepping up where Washington has slowed down. This bill, once enacted into law, will increase transparency and protect consumers from toxic chemicals in New York’s food supply. It represents the most important reform to the U.S. food chemical review process in decades."
The Evolution and Criticisms of the GRAS Pathway
The GRAS (Generally Recognized as Safe) provision was designed to expedite the introduction of ingredients that had a long history of safe use or for which there was broad scientific consensus on their safety. The 1972 amendment introduced the concept of "self-affirmation," allowing manufacturers to make their own GRAS determinations without mandatory notification to the FDA. This pathway has been utilized by the food industry to bring a vast array of ingredients to market, from flavor enhancers and preservatives to novel food components.
However, the lack of mandatory reporting and transparency has become a significant point of contention. Critics argue that this system allows companies to bypass rigorous, independent scientific scrutiny that would be required under a formal FDA review. This can lead to ingredients entering the food supply without public knowledge of their composition, safety data, or potential health implications. The FDA’s own data indicates that it reviews only a limited number of GRAS notices annually – approximately 75 – with an average review time exceeding 160 days. This suggests that the vast majority of ingredients classified as GRAS are not subject to direct FDA evaluation.
Assemblymember Anna Kelles, another co-sponsor of the bill, articulated this concern, stating, "It was never intended to allow new synthetic chemical additives into the food supply without independent oversight or transparency. Over time, through FDA rulemaking, companies have been allowed to determine for themselves that a chemical is safe without notifying the FDA or making the evidence public. As a result, chemicals can enter the food supply and remain there for years or even decades before concerns are identified through independent research." This highlights a fundamental disconnect between the original intent of the GRAS rule and its current application, where proprietary interests and speed to market can potentially overshadow consumer safety.
Key Provisions of the New York Legislation
The New York bill outlines specific requirements for companies that self-affirm GRAS status for ingredients. Manufacturers will be obligated to submit detailed scientific data and safety assessments to state regulators. This information must include:
- Manufacturing Processes: A clear description of how the ingredient is produced.
- Intended Conditions of Use: The specific applications and usage levels within food products.
- Ingredient Source and Composition: Details about the raw materials and the chemical makeup of the ingredient.
- Dietary Exposure Estimates: Projections of how much of the ingredient consumers are likely to ingest.
- Disclosure of All Data: A requirement to present both favorable and unfavorable safety data, ensuring a comprehensive risk assessment.
Upon receiving this information, the New York Department of Agriculture and Markets will be responsible for establishing a public database. This database will provide consumers and researchers with unprecedented access to information about GRAS ingredients used in food and beverage products manufactured or sold within the state. This transparency is intended to empower consumers to make informed purchasing decisions and to facilitate independent scientific inquiry into the safety of food additives.
A crucial element of the legislation is its exemption for small businesses. Independently owned businesses with fewer than 100 employees are not subject to the disclosure requirements. This provision aims to mitigate the potential burden on smaller enterprises while focusing the regulatory oversight on larger corporations that may have greater resources and a more significant market presence. The bill explicitly states that companies not required to disclose under the current definition may not be safeguarding consumer interests, and that undisclosed chemicals can pose serious health risks.
Broader Implications and Industry Response
The passage of this bill in New York signals a growing momentum towards greater accountability in the food industry’s use of self-affirmed GRAS ingredients. This legislative move mirrors similar efforts underway in other states. California has proposed legislation that would grant state officials the authority to conduct safety assessments for GRAS substances independently of the FDA. Lawmakers in New Jersey and Pennsylvania are also exploring comparable measures.
On the federal level, the FDA’s proposed rule to phase out the self-affirmed GRAS pathway is currently under review by the White House. If enacted, this federal rule would require companies to notify the FDA about their GRAS status and obtain a "no questions" letter, confirming the ingredient’s safety for sale. This would significantly alter the regulatory landscape, bringing greater federal oversight to ingredients previously determined solely by manufacturers.
The food industry, however, has voiced strong opposition to New York’s bill. Industry groups, including the American Beverage Association and the National Supermarket Association, whose members include major players like Coca-Cola, PepsiCo, and Keurig Dr Pepper, have characterized the legislation as a "misguided patchwork of food and beverage regulation." They argue that it would impose "huge, duplicative reporting requirements" on businesses, leading to increased costs and consumer confusion. This opposition underscores the significant economic and operational changes that such reforms could necessitate for large food manufacturers.
The potential impact of New York’s legislation extends beyond its borders. Senator Kavanagh expressed optimism that the required public disclosure would have a national reverberation, stating, "Since processed foods are produced and distributed nationally, we hope and expect that the public disclosure required by this legislation will reverberate across the United States, as Americans increasingly demand safety and accountability."
The FDA’s commitment to food safety, particularly in the context of emerging food technologies, has been reiterated by agency officials. They emphasize that the priority is the safety of all food, regardless of production method. However, concerns have also been raised about the potential strain on regulatory resources if a federal mandate for GRAS notifications were to significantly increase the volume of submissions without a corresponding increase in funding. Tony Pavel, a partner at Keller and Heckman LLP and an executive board member of the Precision Fermentation Alliance, previously noted to Green Queen, "If there is a significant increase in GRAS notifications submitted to the FDA by mandate, without increasing funding and resources, review timelines will likely suffer. Currently, manufacturers may assess certain manufacturing changes or improvements without necessitating a filing with the FDA. If this flexibility is lost, there will potentially be significant additional burdens on the industry, as it iterates products through continuous improvement processes."
Timeline and Future Outlook
The New York bill now awaits the signature of Governor Kathy Hochul. She has until the end of the year to decide on its fate. If signed into law, the new GRAS disclosure rules would take effect one year after enactment, allowing businesses a transition period to comply with the reporting requirements.
In addition to the GRAS reform, the legislation includes an immediate ban on the use of three specific food additives: Red Dye No. 3, potassium bromate, and propylparaben. While retailers will be permitted to sell existing products containing these substances until their expiration dates, the ban on their inclusion in new products will come into effect three years after the bill’s enactment.
The passage of this bill represents a significant victory for consumer advocates and public health organizations pushing for greater transparency and accountability in the food supply chain. It highlights a growing public demand for clearer information about the ingredients that make up the foods consumed daily. As other states consider similar legislation and the FDA navigates its own proposed reforms, New York’s actions could serve as a crucial catalyst in reshaping the regulatory landscape for food ingredients in the United States. The ongoing debate between industry concerns over regulatory burden and consumer demands for safety and transparency will continue to shape the future of food regulation.